Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Why Is Virtuix Holdings (NASDAQ:VTIX) in the Spotlight Today?

Virtuix Holdings Inc. (NASDAQ:VTIX) was featured in a Bloomberg Television broadcast on August 22, spotlighting the company's immersive virtual reality technology alongside two other public companies addressing different market opportunities. The sponsored programming segment aired across Bloomberg Television in the United States, Latin America, …

Nitish Kishor | 24 August 2026

Why Is SI-BONE (NASDAQ:SIBN) Rising 4% Pre-Market Today?

SI-BONE, Inc. (NASDAQ:SIBN) shares climbed further in pre-market trading, extending recent momentum as investors weigh a series of heavy insider stock sales against strong underlying fundamentals following the company's second-quarterEarningsbeat. The stock's advance follows a string of bullish analyst actions, including initiating coverage with …

Nitish Kishor | 24 August 2026

Why Is SafeSpace Global (OTCID:SSGC) in the Spotlight Today?

SafeSpace Global Corporation (OTCID:SSGC) was featured in a Bloomberg Television broadcast on August 22, highlighting the company's artificial intelligence-powered physical security platform designed to help schools, senior-living facilities, and other organizations identify potential threats earlier. The sponsored programming segment aired alongside features on two …

Nitish Kishor | 24 August 2026

REGENXBIO (NASDAQ:RGNX) Falls 21% Pre-Market on FDA Clinical Hold

REGENXBIO Inc. (NASDAQ:RGNX) shares dropped sharply in pre-market trading after the U.S. Food and Drug Administration placed a clinical hold on RGX-121, the company's investigational gene therapy for Mucopolysaccharidosis type II, also known as Hunter Syndrome. The hold followed the discovery of asymptomatic spine …

Nitish Kishor | 24 August 2026

Why Is Atrium Therapeutics (NASDAQ:RNA) Falling Pre-Market Today?

Atrium Therapeutics, Inc. (NASDAQ:RNA) shares fell in pre-market trading following the company's disclosure of inducement equity grants awarded to a newly hired non-executive employee under its 2026 Employment Inducement Incentive Award Plan. The grants, a standard practice for attracting talent at growing biotechnology companies, …

Nitish Kishor | 24 August 2026

This Nasdaq Parkinson's Stock Slides 5% Pre-Market Even After National TV Spotlight

BioVie Inc. (NASDAQ:BIVI) shares declined in pre-market trading even after the company was featured in a Bloomberg Television broadcast highlighting its investigational Parkinson's disease therapy, bezisterim. The segment, distributed through a sponsored financial media platform, spotlighted the company's Phase 2 SUNRISE-PD trial results alongside …

Nitish Kishor | 24 August 2026

Biomea Fusion (NASDAQ:BMEA) Rises 8% Pre-Market on Trial Enrollment Milestone

Biomea Fusion, Inc. (NASDAQ:BMEA) shares rose in pre-market trading after the company announced completion of enrollment in COVALENT-211, a randomized, double-blinded, placebo-controlled Phase II trial evaluating its lead candidate icovamenib in patients with insulin-deficient type 2 diabetes who remain inadequately controlled on standard-of-care therapies.

Nitish Kishor | 24 August 2026

This Nasdaq TechBio Stock Pulls Back Pre-Market After Sharp Multi-Week Rally

Caris Life Sciences, Inc. (NASDAQ:CAI) shares pulled back modestly in pre-market trading, giving back a small portion of a powerful multi-week rally that has taken the stock roughly 65% to 73% higher off its May lows. The pullback follows an August 5 earnings report …

Nitish Kishor | 24 August 2026

GeoVax Labs (NASDAQ:GOVX) Rises 8% Pre-Market Ahead of CEO Conference Appearance

GeoVax Labs, Inc. (NASDAQ:GOVX) shares rose in pre-market trading ahead of Chairman, President and Chief Executive Officer David Dodd's participation in the 2026 Georgia Life Sciences Summit, scheduled for August 25 and 26 in Sandy Springs, Georgia. Dodd, a former chair of Georgia Life …

Nitish Kishor | 24 August 2026

This NYSE American Oncology Stock Slides 11% Pre-Market Ahead of 1-for-7 Reverse Split

Kairos Pharma, Ltd. (NYSE American:KAPA) shares fell in pre-market trading ahead of the company's previously announced 1-for-7 reverse stock split, which is set to become effective at 12:01 a.m. Eastern Time on September 1, 2026. Shares are expected to begin trading on a split-adjusted …

Nitish Kishor | 24 August 2026
Support

Hi! How can we help you today?

Loading…